WASHINGTON, DC (GenomeWeb News) – Australian molecular diagnostics developer Proteome Systems has closed a private placement of AUD$2.5 million (US$2.2 million), the company said today.
 
Proteome Systems will issue 23,809,524 shares at AUD$0.105 per share to participants in the funding including Oppenheimer Funds and other US and Australian investors.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.